According to Lin’s findings, increased expression of ARSD might contribute to amyloidosis in breast cancer cells, and therefore targeting ARSD could be a potential strategy for treating TNBC or Alzheimer’s disease (AD) (11). This evidence concerns the gene ARSD and Alzheimer disease.